298 related articles for article (PubMed ID: 21444677)
41. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
[TBL] [Abstract][Full Text] [Related]
42. The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers.
Maqbool R; Rashid R; Ismail R; Niaz S; Chowdri NA; Hussain MU
Cell Oncol (Dordr); 2015 Dec; 38(6):443-51. PubMed ID: 26335100
[TBL] [Abstract][Full Text] [Related]
43. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.
Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F
Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722
[TBL] [Abstract][Full Text] [Related]
44. TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer.
Breunig C; Erdem N; Bott A; Greiwe JF; Reinz E; Bernhardt S; Giacomelli C; Wachter A; Kanthelhardt EJ; Beißbarth T; Vetter M; Wiemann S
Mol Oncol; 2018 Sep; 12(9):1447-1463. PubMed ID: 30004628
[TBL] [Abstract][Full Text] [Related]
45. The expression and regulation of microRNA-125b in cancers.
Huang K; Dong S; Li W; Xie Z
Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):803-5. PubMed ID: 23800395
[TBL] [Abstract][Full Text] [Related]
46. miR-204 is dysregulated in metastatic prostate cancer in vitro.
Todorova K; Metodiev MV; Metodieva G; Zasheva D; Mincheff M; Hayrabedyan S
Mol Carcinog; 2016 Feb; 55(2):131-47. PubMed ID: 25630658
[TBL] [Abstract][Full Text] [Related]
47. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.
Yang Q; Wang Y; Lu X; Zhao Z; Zhu L; Chen S; Wu Q; Chen C; Wang Z
Oncotarget; 2015 Feb; 6(5):3268-79. PubMed ID: 25605244
[TBL] [Abstract][Full Text] [Related]
48. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1.
Han Y; Liu Y; Zhang H; Wang T; Diao R; Jiang Z; Gui Y; Cai Z
FEBS Lett; 2013 Nov; 587(23):3875-82. PubMed ID: 24396870
[TBL] [Abstract][Full Text] [Related]
49. Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells.
Neel JC; Lebrun JJ
Cell Signal; 2013 Jul; 25(7):1556-66. PubMed ID: 23524334
[TBL] [Abstract][Full Text] [Related]
50. Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.
Gu J; Chen Y; Huang H; Yin L; Xie Z; Zhang MQ
Mol Biosyst; 2014 Dec; 10(12):3249-54. PubMed ID: 25286864
[TBL] [Abstract][Full Text] [Related]
51. High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis.
Hong L; Yang J; Han Y; Lu Q; Cao J; Syed L
Gene; 2012 Oct; 507(2):135-8. PubMed ID: 22842193
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.
Zhou M; Liu Z; Zhao Y; Ding Y; Liu H; Xi Y; Xiong W; Li G; Lu J; Fodstad O; Riker AI; Tan M
J Biol Chem; 2010 Jul; 285(28):21496-507. PubMed ID: 20460378
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression.
Zhong XY; Yu JH; Zhang WG; Wang ZD; Dong Q; Tai S; Cui YF; Li H
Gene; 2012 Feb; 493(1):44-51. PubMed ID: 22146319
[TBL] [Abstract][Full Text] [Related]
54. MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b.
Zhang J; Lu L; Xiong Y; Qin W; Zhang Y; Qian Y; Jiang H; Liu W
Clin Exp Dermatol; 2014 Apr; 39(3):376-84. PubMed ID: 24635082
[TBL] [Abstract][Full Text] [Related]
55. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J
Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310
[TBL] [Abstract][Full Text] [Related]
56. The oncogenic role of miR-155 in breast cancer.
Mattiske S; Suetani RJ; Neilsen PM; Callen DF
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1236-43. PubMed ID: 22736789
[TBL] [Abstract][Full Text] [Related]
57. miR-23b-3p and miR-125b-5p downregulate apo(a) expression by targeting Ets1 in HepG2 cells.
Zeng JF; Zeng ZL; Zhang K; Zhao Y; Liu YM; Chen JJ; Tong H; Wei DH; Jiang ZS; Wang Z
Cell Biol Int; 2018 Mar; 42(3):313-323. PubMed ID: 29064597
[TBL] [Abstract][Full Text] [Related]
58. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation.
Guan Y; Yao H; Zheng Z; Qiu G; Sun K
Int J Cancer; 2011 May; 128(10):2274-83. PubMed ID: 20658525
[TBL] [Abstract][Full Text] [Related]
59. The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
Xie X; Hu Y; Xu L; Fu Y; Tu J; Zhao H; Zhang S; Hong R; Gu X
Tumour Biol; 2015 Sep; 36(9):7185-94. PubMed ID: 25894378
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.
Tang F; Zhang R; He Y; Zou M; Guo L; Xi T
PLoS One; 2012; 7(5):e35435. PubMed ID: 22693547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
